a Study to Investigate the Efficacy, and Safety of the Colovac Colorectal Anastomosis Protection Device.

Inclusion criteria

• Subject must be >= 18 and <= 65 years old
• Indicated for colorectal resection
• Patient has been assessed by a multi-disciplinary team and it was determined that as per standard of care, they are eligible to bear a diverting ostomy
• Willing to comply with protocol-specified follow-up evaluations
• Signed Informed Consent

Exclusion criteria

• Patient with inflammatory bowel disease
• Pregnant or nursing female subject (a pregnancy test should be conducted the day prior to the procedure for all women in age of procreating)
• Known allergy to nickel or other components of the Colovac kit
• Any significant medical condition which, in the investigator's opinion, may interfere with the subject's optimal participation in the study, including:

• immunodeficiency
• steroid therapy
• infections at the time of intervention
• major surgical or interventional procedures within 30 days prior to this study or planned surgical or interventional procedures within 30 days of entry into this study
• diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel perforation, local or systemic infection, ischemic bowel, carcinomatosis
• preexisting sphincter problems or evidence of extensive local disease in the pelvis
• blood loss (> 500 cc)
• non amended peroperative anastomosis failure
• intra-operative adverse events
• malnourishment
• obesity (BMI > 35)
• history of excessive smoking and alcohol use
• The subject is currently participating in another investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the endpoints of this study
• Patient unable to give consent